Target Price | $61.43 |
Price | $44.53 |
Potential |
37.96%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Zepp Health ADR A ADR 2026 .
The average Zepp Health ADR A ADR target price is $61.43.
This is
37.96%
register free of charge
$63.24
42.02%
register free of charge
$60.83
36.61%
register free of charge
|
|
A rating was issued by 7 analysts: 6 Analysts recommend Zepp Health ADR A ADR to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Zepp Health ADR A ADR stock has an average upside potential 2026 of
37.96%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 182.60 | 1,738.00 |
48.25% | 851.81% | |
EBITDA Margin | -23.13% | -9.28% |
258.55% | 59.87% | |
Net Margin | -41.47% | -11.77% |
371.77% | 71.62% |
3 Analysts have issued a sales forecast Zepp Health ADR A ADR 2025 . The average Zepp Health ADR A ADR sales estimate is
This results in the following potential growth metrics:
3 Zepp Health ADR A ADR Analysts have issued a net profit forecast 2025. The average Zepp Health ADR A ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.29 | -0.88 |
123.08% | 203.45% | |
P/E | negative |
3 Analysts have issued a Zepp Health ADR A ADR forecast for earnings per share. The average Zepp Health ADR A ADR EPS is
This results in the following potential growth metrics and future valuations:
Zepp Health ADR A ADR...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.